News Search Filter :
 
From Date :
   
To Date :
   
Results Per Page:

 
Company Search:
 
Company Name:
Symbol Lookup:
Results Per Page:
 

You are not registered on World Stock Wire.
[ Sign up for a Free Account ] [ Log in ]

efoodsafety.com, Inc. (EFSF), USA
2008-04-24 15:50:58 EST

eFoodSafety's Cinnechol Positioned to Make In-Roads in Cholesterol Market

Scottsdale, AZ - (WORLD STOCK WIRE) - April 24, 2008 -- Cholesterol-lowering drugs comprise the largest drugs class in the U.S., amounting to over $20 billion annually. Of that total, revenue for the top three selling prescription drugs in this category - Vytorin, Zocor, and Lipitor - has historically accounted for approximately $13 billion. In recent news, however, certain of these top-selling drugs have faced question concerning efficacy and/or potential risk factors. Consumer wariness, coupled with increased costs of medications, may invite room in the market for complementary and/or alternative options to address consumers' needs.

eFoodSafety.com, Inc. (OTCBB: EFSF) has developed and introduced to market one such product: Cinnechol (www.cinnechol.com), an all-natural supplement designed to help normalize cholesterol and triglycerides levels, as well as enhance overall cardiovascular health.

While approximately sixteen million Americans currently take drugs to reduce cholesterol, many of these drugs have serious limitations and/or side effects. One of the more common is Myalgia, or muscle pain, which can at times be severe. Also, this class of drugs does not generally address other factors such as elevated triglycerides and diminished circulation. To complicate matters for consumers, drug costs and co-payment expenses are on the rise. Over the past year, generic drugs have gained market share over their prescription counterparts, which can cost about one-third the price of brand name treatments. In light of this current climate, some people may realize value in seeking other, over-the-counter options, such as Cinnechol.

As an all-natural supplement designed to promote healthy total and LDL, or "bad" cholesterol levels, Cinnechol has no known adverse side effects. Furthermore, it also aims to promote healthy triglyceride levels and support overall circulatory health. The ingredients in Cinnechol also work synergistically to decrease the viscosity, or thickness of the blood, allowing for better circulation, and assisting in fighting inflammation which is vital to the health of the heart and blood vessels.

"The controversy surrounding certain cholesterol medications as well as the escalating prices, may pave the way for other options, including not only generic alternatives, but also all-natural ones," says Patricia Gruden, CEO of eFoodSafety.

For more information on Cinnechol, please visit www.cinnechol.com.

About eFoodSafety.com
eFoodSafety.com, Inc., based in Scottsdale, Arizona, is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin(TM) (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, as well as Avian Influenza. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The OraPhyte(TM) product, which has been tested and shown to be effective at eradicating nematodes by the U.S. Department of Agriculture, is currently at three major universities with outstanding Agricultural Departments undergoing crop-specific research.

The company's Cinnergen(TM) is a clinically-researched, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism, is available for sale at (www.cinnergendirect.com) and through national retailers; its Cinnechol(TM) (www.cinnechol.com) is a multi-faceted nutritional supplement specifically designed to naturally promote healthy cholesterol and triglyceride levels without causing any side effects, as well as enhance overall cardiovascular health. The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.

The company's iBoost, Inc. subsidiary is the distributor of the Immune Boost Bar(TM), a non-dairy, no refined sugar, all-natural and comprehensive multi-nutrient product that helps fortify the body's immune system. The product contains Citroxin O2(TM), eFoodSafety's proprietary all natural supplement proven effective in fighting several types of harmful bacteria, and forty active compounds that assist with enhancing immunity, detoxification, cleansing, and metabolic efficiency. The Immune Boost Bar(TM) is available in four delicious flavors: chocolate, oatmeal-raisin, chocolate mint and peanut butter and can be purchased at www.immuneboost.com.

The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the owner of the Talsyn(TM)-CI/bid Scar Cream, a product that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line.

Please visit the company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.



Patricia Gruden
efoodsafety.com, Inc.
7702 East Doubletree Ranch Road
Suite 300
Scottsdale, AZ 85258
USA

Phone: 415-884-0348
Fax: 480-348-3999


Source: efoodsafety.com, Inc.
Note: The following press release was submitted by: efoodsafety.com, Inc., and World Stock Wire, Inc. is not liable for the contents of this press release.